Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes

Journal of Neurochemistry

Volumn 94, Issue 3, 2005, Pages 561-571

  Masmoudi, Olfa ^a   Gandolfo, Pierrick ^a   Tokay, Tursonjan ^a   Leprince, Jérôme ^a   Ravni, Aurélia ^a   Vaudry, Hubert ^a   Tonon, Marie Christine ^a  

^a UNIVERSITÉ DE ROUEN   (France)

Author keywords

Astrocytes; Diazepam binding inhibitor; Mitogen activated protein kinase; Octadecaneuropeptide; Protein kinase A; Somatostatin

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ADENYLATE CYCLASE; CALPHOSTIN C; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIAZEPAM BINDING INHIBITOR; FORSKOLIN; L 779591; L 779976; L 797778; L 803087; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; OCTADECANEUROPEPTIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE C INHIBITOR; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; SOMATOSTATIN; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 3; SOMATOSTATIN RECEPTOR 4; UNCLASSIFIED DRUG;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; IC 50; INCUBATION TIME; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BLOTTING, NORTHERN; BRAIN; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLIC AMP; DIAZEPAM BINDING INHIBITOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG INTERACTIONS; ENZYME INHIBITORS; FORSKOLIN; NEUROPEPTIDES; PEPTIDE FRAGMENTS; PHENANTHROLINES; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOMATOSTATIN; TIME FACTORS;

EID: 23244457660     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03076.x     Document Type: Article

References (73)

1. Alho H., Harjuntausta T., Schultz R., Pelto-Huikko M. and Bovolin P. (1991) Immunohistochemistry of diazepam binding inhibitor (DBI) in the central nervous system and peripheral organs: its possible role as an endogenous regulator of different types of benzodiazepine receptors. Neuropharmacology 30, 1381-1386.
2. Alho H., Kolmer M., Harjuntausta T. and Helen P. (1995) Increased expression of diazepam binding inhibitor in human brain tumors. Cell. Growth Differ. 6, 309-314.
3. Barbaccia M. L., Costa E., Ferrero P., Guidotti A., Roy A., Sunderland T., Pickar D., Paul S. M. and Goodwin F. K. (1986) Diazepam-binding inhibitor. A brain neuropeptide present in human spinal fluid: studies in depression, schizophrenia, and Alzheimer's disease. Arch. Gen. Psychiatry 43, 1143-1147.
4. 1-subtype-selective nonpeptidyl agonist. Neuropharmacology 40, 590-596.
5. A receptors. Neuropharmacology 30, 1387-1389.
6. Boudin H., Sarret P., Mazella J., Schonbrunn A. and Beaudet A. (2000) Somatostatin-induced regulation of SST(2A) receptor expression and cellsurface availability in central neurons: role of receptor intemalization. J. Neurosci. 20, 5932-5939.
7. Bovolin P., Schlichting J., Miyata M., Ferrarese C., Guidotti A. and Alho H. (1990) Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat. Regul. Pept. 29, 267-281.
8. Brown D. R. and Mohn C. M. (1999) Astrocytic glutamate uptake and prion protein expression. Glia 25, 282-292.
9. Candiani S., Augello A., Oliveri D. and Pestarino M. (2000) Immunoreactive endozepine-like peptides in the brain and pituitary of the Atlantic hagfish, Myxine glutinosa. Histochem. J. 32, 415-421.
10. Cervia D., Zizzari P., Pavan B., Schuepbach E., Langenegger D., Hoyer D., Biondi C., Epelbaum J. and Bagnoli P. (2003) Biological activity of somatostatin receptors in GC rat tumour somatotrophs: evidence with sst1-sst5 receptor-selective nonpeptidyl agonists. Neuropharmacology 44, 672-685.
11. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
12. Costa E., Corda M. G. and Guidotti A. (1983) On a brain polypeptide functioning as a putative effector for the recognition sites of benzodiazepine and β-carboline derivatives. Neuropharmacology 22, 1481-1492.
13. Csaba Z. and Doumaud P. (2001) Cellular biology of somatostatin receptors. Neuropeptides 35, 1-23.
14. De Mateos-Verchère J. G., Leprince J., Tonon M. C., Vaudry H. and Costentin J. (1998a) The octadecaneuropeptide ODN induces anxiety in rodents: possible involvement of a shorter biologically active fragment. Peptides 19, 841-848.
15. De Mateos-Verchère J. G., Leprince J., Tonon M. C., Vaudry H. and Costentin J. (1998b) The octadecaneuropeptide ODN inhibits apomorphine-induced yawning in rats. Eur. J. Pharmacol. 357, 121-126.
16. De Mateos-Verchère J. G., Leprince J., Tonon M. C., Vaudry H. and Costentin J. (1999) Reduction of pentylenetetrazol-induced convulsions by the octadecaneuropeptide ODN. Peptides 20, 1431-1436.
17. De Mateos-Verchère J. G., Leprince J., Tonon M. C., Vaudry H. and Costentin J. (2001) The octadecaneuropeptide [diazepam-binding inhibitor (33-50)] exerts potent anorexigenic effects in rodents. Eur. J. Pharmacol. 414, 225-231.
18. Do-Régo J. L., Mensah-Nyagan A. G., Beaujean D., Leprince J., Tonon M. C., Luu-The V, Pelletier G. and Vaudry H. (2001) The octa-decaneuropeptide ODN stimulates neurosteroid biosynthesis through activation of central-type benzodiazepine receptors. J. Neurochem. 76, 128-138.
19. Epelbaum J. (1986) Somatostatin in the central nervous system: physiology and pathological modifications. Prog. Neurobiol. 27, 63-100.
20. Evans T., McCarthy K. D. and Harden T. K. (1984) Regulation of cyclic AMP accumulation by peptide hormone receptors in immunocytochemically defined astroglial cells. J. Neurochem. 43, 131-138.
21. Feindt J., Becker I., Blomer U., Hugo H. H., Mehdom H. M., Krisch B. and Mentlein R. (1995) Expression of somatostatin receptor subtypes in cultured astrocytes and gliomas. J. Neurochem. 65, 1997-2005.
22. Ferrarese C., Appollonio I., Frigo M., Meregalli S., Piolti R., Tamma F. and Frattola L. (1990) Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia. Neurology 40, 632-635.
23. Ferrarese C., Cogliati T., Tortorella R. et al. (1998) Diazepam binding inhibitor (DBI) in the plasma of pediatric and adult epileptic patients. Epilepsy Res. 29, 129-134.
24. Ferrero P., Santi M. R., Conti-Tronconi B., Costa E. and Guidotti A. (1986) Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc. Natl. Acad. Sci. USA 83, 827-831.
25. 2+ in rat astrocytes is not mediated through classical benzodiazepine receptors. Eur. J. Pharmacol. 322, 275-281.
26. Grimaldi M., Florio T. and Schettini G. (1997) Somatostatin inhibits interleukin 6 release from rat cortical type I astrocytes via the inhibition of adenylyl cyclase. Biochem. Biophys. Res. Commun. 235, 242-248.
27. Guidotti A., Forchetti C. M., Corda M. G., Konkel D., Bennett C. D. and Costa E. (1983) Isolation, characterization, and purification to homogeneity of an endogenous polypeptide with agonistic action on benzodiazepine receptors. Proc. Natl Acad. Sci. USA 80, 3531-3535.
28. Hansen H. O., Andreasen P. H., Mandrup S., Kristiansen K. and Knudsen J. (1991) Induction of acyl-CoA-binding protein and its mRNA in 3T3-L1 cells by insulin during preadipocyte-to-adipocyte differentiation. Biochem. J. 277, 341-344.
29. Hosli E. and Hosli L. (2000) Colocalization of neurotransmitter receptors on astrocytes in explant cultures of rat CNS. Neurochem. Int. 36, 301-311.
30. Khare S., Kumar U., Sasi R., Puebla L., Calderon L., Lemstrom K., Hayry P. and Patel A. Y. (1999) Differential regulation of somatostatin receptor types 1-5 in rat aorta after angioplasty. FASEB J. 13, 387-394.
31. Kolmer M., Alho H., Costa E. and Pani L. (1993) Cloning and tissue-specific functional characterization of the promoter of the rat diazepam binding inhibitor, a peptide with multiple biological actions. Proc. Natl Acad. Sci. USA 90, 8439-8443.
32. Krisch B. (1994) Somatostatin binding sites in functional systems of the brain. Prog. Histochem. Cytochem. 28, 1-40.
33. Lamacz M., Tonon M. C., Smih-Rouet F., Patte C., Gasque P., Fontaine M. and Vaudry H. (1996) The endogenous benzodiazepine receptor ligand ODN increases cytosolic calcium in cultured rat astrocytes. Mol. Brain Res. 37, 290-296.
34. Lamszus K., Meyerhof W. and Westphal M. (1997) Somatostatin and somatostatin receptors in the diagnosis and treatment of gliomas. J. Neurooncol. 35, 353-364.
35. Lang S., Peigen K., Liu J., Zhang F., Chen X. and Liu Z. (1992) Somatostatin concentrations in cerebrospinal fluid and brain tissue of patients with refractory epilepsy. Mol. Chem. Neuropathol. 17, 239-247.
36. Leprince J., Gandolfo P., Thoumas J. L., Patte C., Fauchère J. L., Vaudry H. and Tonon M. C. (1998) Structure-activity relationships of a series of analogues of the octadecaneuropeptide ODN on calcium mobilization in rat astrocytes. J. Med. Chem. 41, 4433-4438.
37. Leprince J., Oulyadi H., Vaudry D. et al. (2001) Synthesis, conformational analysis and biological activity of cyclic analogs of the octadecaneuropeptide ODN. Design of a potent endozepine antagonist. Eur. J. Biochem. 268, 6045-6057.
38. Liu Q. and Schonbrunn A. (2001) Agonist-induced phosphorylation of somatostatin receptor subtype 1 (sstl): relationship to desensitization and internalization. J. Biol. Chem. 276, 3709-3717.
39. Malagon M., Vaudry H., Van Strien F., Pelletier G., Gracia-Navarro F. and Tonon M. C. (1993) Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain. Neuroscience 57, 777-786.
40. Mandrup S., Hummel R., Ravn S., Jensen G., Andreasen P. H., Gregersen N., Knudsen J. and Kristiansen K. (1992) Acyl-CoA-binding protein/diazepam-binding inhibitor gene and pseudogenes. A typical housekeeping gene family. J. Mol. Biol. 228, 1011-1022.
41. Marino F., Cosentino M., Fietta A. M., Ferrari M., Cattaneo S., Frigo G., Lecchini S. and Frigo G. M. (2003) Interleukin-8 production induced by the endozepine triakontatetraneuropeptide in human neutrophils: role of calcium and pharmacological investigation of signal transduction pathways. Cell Signal. 15, 511-517.
42. Masmoudi O., Gandolfo P., Leprince J., Vaudry D., Foumier A., Patte-Mensah C., Vaudry H. and Tonon M. C. (2003) Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism. FASEB J. 17, 17-27.
43. Mentlein R. and Dahms P. (1994) Endopeptidases 24.16 and 24.15 are responsible for the degradation of somatostatin, neurotensin, and other neuropeptides by cultivated rat cortical astrocytes. J. Neurochem. 62, 27-36.
44. Mentlein R., Buchholz C. and Krisch B. (1990) Somatostatin-binding sites on rat telencephalic astrocytes. Light- and electron-microscopic studies in vitro and in vivo. Cell Tissue Res. 262, 431-443.
45. Meyerhof W. (1998) The elucidation of somatostatin receptor functions: a current view. Rev. Physiol. Biochem. Pharmacol. 133, 55-108.
46. Molchan S. E., Hill J. L., Martinez R. A., Lawlor B. A., Mellow A. M., Rubinow D. R., Bissette G., Nemeroff C. B. and Sunderland T. (1993) CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures. Psychoneuroendocrinology 18, 509-519.
47. Papadopoulos V., Berkovich A., Krueger K. E., Costa E. and Guidotti A. (1991) Diazepam binding inhibitor and its processing products stimulate mitochondrial steroid biosynthesis via an interaction with mitochondrial benzodiazepine receptors. Endocrinology 129, 1481-1488.
48. Patel R. C., Kumar U., Lamb D. C. et al. (2002) Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. Proc. Natl. Acad. Sci. USA 99, 3294-3299.
49. 25]somatostatin-28-binding sites in rat brain. Endocrinology 119, 2262-2269.
50. Patel Y. C., Panetta R., Escher E., Greenwood M. and Srikant C. B. (1994) Expression of multiple somatostatin receptor genes in AtT-20 cells. Evidence for a novel somatostatin-28 selective receptor subtype. J. Biol. Chem. 269, 1506-1509.
51. Patel Y. C., Greenwood M. T., Panetta R., Demchyshyn L., Niznik H. and Srikant C. B. (1995) The somatostatin receptor family. Life Sci. 57, 1249-1265.
52. Patte C., Vaudry H., Desrues L., Gandolfo P., Strijdveen I., Lamacz M. and Tonon M. C. (1995) The endozepine ODN stimulates polyphosphoinositide metabolism in rat astrocytes. FEBS Lett. 362, 106-110.
53. Patte C., Gandolfo P., Leprince J., Thoumas J. L., Fontaine M., Vaudry H. and Tonon M. C. (1999) GABA inhibits endozepine release from cultured rat astrocytes. Glia 25, 404-411.
54. Pfeiffer M., Koch T., Schroder H., Klutzny M., Kirscht S., Kreienkamp H. J., Hollt V. and Schulz S. (2001) Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J. Biol. Chem. 276, 14 027-14 036.
55. Pitkanen A., Jolkkonen J., Aikia M., Sirvio J., Sivenius J. and Riekkinen P. J. (1988) Somatostatin-like immunoreactivity in cerebrospinal fluid of patients with complex partial epilepsy. Eur. Neurol. 28, 1-5.
56. Reisine T. and Bell G. I. (1995) Molecular biology of somatostatin receptors. Endocr. Rev. 16, 427-442.
57. Rocheville M., Lange D. C., Kumar U., Sasi R., Patel R. C. and Patel Y. C. (2000) Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J. Biol. Chem. 275, 7862-7869.
58. Roosterman D., Roth A., Kreienkamp H. J., Richter D. and Meyerhof W. (1997) Distinct agonist-mediated endocytosis of cloned rat somatostatin receptor subtypes expressed in insulinoma cells. J. Neuroendocrinol. 9, 741-751.
59. Roth A., Kreienkamp H. J., Nehring R. B., Roosterman D., Meyerhof W. and Richter D. (1997) Endocytosis of the rat somatostatin receptors: subtype discrimination, ligand specificity, and delineation of carboxy-terminal positive and negative sequence motifs. DNA Cell Biol. 16, 111-119.
60. Roy A. (1991) Cerebrospinal fluid diazepam binding inhibitor in depressed patients and normal controls. Neuropharmacology 30, 1441-1444.
61. Rubinow D. R. (1986) Cerebrospinal fluid somatostatin and psychiatric illness. Biol. Psychiatry 21, 341-365.
62. Rubinow D. R., Gold P. W., Post R. M., Ballenger J. C., Cowdry R., Bollinger J. and Reichlin S. (1983) CSF somatostatin in affective illness. Arch. Gen. Psychiatry 40, 409-412.
63. Sakanaka C., Ferby I., Waga I., Bito H. and Shimizu T. (1994) On the mechanism of cytosolic phospholipase A2 activation in CHO cells carrying somatostatin receptor: wortmannin-sensitive pathway to activate mitogen-activated protein kinase. Biochem. Biophys. Res. Commun. 205, 18-23.
64. Slobodyansky E., Guidotti A., Wambebe C., Berkovich A. and Costa E. (1989) Isolation and characterization of a rat brain triakontatetra- neuropeptide, a posttranslational product of diazepam binding inhibitor: specific action at the Ro 5-4864 recognition site. J. Neurochem. 53, 1276-1284.
65. Slobodyansky E., Antkiewicz-Michaluk L. and Martin B. (1994) Purification of a novel DBI processing product, DBI39-75, and characterization of its binding site in rat brain. Regul. Pept. 50, 29-35.
66. Stroh T., Jackson A. C., Dal Farra C., Schonbrunn A., Vincent J. P. and Beaudet A. (2000) Receptor-mediated internalization of somatostatin in rat cortical and hippocampal neurons. Synapse 38, 177-186.
67. Swinnen J. V., Esquenet M., Rosseels J., Claessens F., Rombauts W., Heyns W. and Verhoeven G. (1996a) A human gene encoding diazepam-binding inhibitor/acyl-CoA-binding protein: transcription and hormonal regulation in the androgen-sensitive human prostatic adenocarcinoma cell line LNCaP. DNA Cell Biol. 15, 197-208.
68. Swinnen J. V., Vercaeren I., Esquenet M., Heyns W. and Verhoeven G. (1996b) Androgen regulation of the messenger RNA encoding diazepam-binding inhibitor/acyl-CoA-binding protein in the rat. Mol. Cell. Endocrinol. 118, 65-70.
69. Swinnen J. V., Alen P., Heyns W. and Verhoeven G. (1998) Identification of diazepam-binding Inhibitor/Acyl-CoA-binding protein as a sterol regulatory element-binding protein-responsive gene. J. Biol. Chem. 273, 19938-19944.
70. Tong Y., Toranzo D. and Pelletier G. (1991) Localization of diazepam-binding inhibitor (DBI) mRNA in the rat brain by high resolution in situ hybridization. Neuropeptides 20, 33-40.
71. Tonon M. C., Désy L., Nicolas P., Vaudry H. and Pelletier G. (1990) Immunocytochemical localization of the endogenous benzodiazepine ligand octadecaneuropeptide (ODN) in the rat brain. Neuropeptides 15, 17-24.
72. Vaudry H., Tonon M. C., Delarue C., Vaillant R. and Kraicer J. (1978) Biological and radioimmunological evidence for melanocyte stimulating hormones (MSH) of extrapituitary origin in the rat brain. Neuroendocrinology 27, 9-24.
73. Veber D. R, Holly F. W., Nutt R. F., Bergstrand S. J., Brady S. F., Hirschmann R., Glitzer M. S. and Saperstein R. (1979) Highly active cyclic and bicyclic somatostatin analogues of reduced ring size. Nature 280, 512-514.